melanotan i (Afamelanotide) - Pigmentation / α-MSH Analogues Melanotan I 13mg - Polaris

For patients on GLP-1 therapy who want to preserve lean muscle, we often layer in a CJC-1295/Ipamorelin stack

Circulation 1988;77:767-73

Metabolic profiling by Seahorse assay suggested that melatonin treated ILC2s exhibited decreased rates of basal respiration ( Figure 5P ), decreased spare respiratory capacity ( Figure 5Q ), and both reduced active rates of glycolysis ( Figure 5R ) as well as reduced glycolytic capacity ( Figure 5S )

Its relatively small, stable nonapeptide structure makes it a practical tool for studying receptor binding kinetics and neuroendocrine signalling in vitro

The AP is solely responsible for all content

References Division of Dermatology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand